Core Viewpoint - Meihao Medical's stock price has shown volatility, with a slight increase recently, but a decline over the past five trading days and year-to-date. The company operates in the medical device sector, focusing on the design, development, manufacturing, and sales of medical equipment components [1][2]. Financial Performance - For the first half of 2025, Meihao Medical reported a revenue of 733 million yuan, representing a year-on-year growth of 3.73%. However, the net profit attributable to shareholders decreased by 32.44% to 114 million yuan [2]. - Since its A-share listing, Meihao Medical has distributed a total of 248 million yuan in dividends [3]. Stock Market Activity - As of October 15, Meihao Medical's stock price was 22.99 yuan per share, with a market capitalization of 13.078 billion yuan. The stock has experienced a year-to-date decline of 0.49% and a significant drop of 8.19% over the last five trading days [1]. - The stock has been featured on the "Dragon and Tiger List" twice this year, with the most recent appearance on August 25 [1]. Shareholder Structure - As of September 19, the number of shareholders for Meihao Medical was 15,000, a decrease of 7.94% from the previous period. The average number of circulating shares per shareholder increased by 8.63% to 10,418 shares [2]. - The top shareholders include Huabao Zhongzheng Medical ETF and several new institutional investors, indicating a shift in the shareholder base [3].
美好医疗涨2.04%，成交额3644.94万元，主力资金净流入7.50万元